Results     09-May-24
Announcements
Alembic Pharmaceuticals consolidated net profit rises 16.78% in the March 2024 quarter
Sales rise 7.86% to Rs 1516.98 crore
Net profit of Alembic Pharmaceuticals rose 16.78% to Rs 178.21 crore in the quarter ended March 2024 as against Rs 152.60 crore during the previous quarter ended March 2023. Sales rose 7.86% to Rs 1516.98 crore in the quarter ended March 2024 as against Rs 1406.45 crore during the previous quarter ended March 2023.

For the full year,net profit rose 80.07% to Rs 615.82 crore in the year ended March 2024 as against Rs 341.99 crore during the previous year ended March 2023. Sales rose 10.19% to Rs 6228.63 crore in the year ended March 2024 as against Rs 5652.62 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales1516.981406.45 8 6228.635652.62 10
OPM %17.1214.49 -14.9711.98 -
PBDT252.33190.29 33 904.50630.02 44
PBT182.85116.17 57 631.83354.59 78
NP178.21152.60 17 615.82341.99 80

Previous News
  Alembic Pharmaceuticals consolidated net profit rises 16.78% in the March 2024 quarter
 ( Results - Announcements 09-May-24   15:06 )
  Alembic Pharmaceuticals update on its Namthang facility in Sikkim
 ( Corporate News - 04-Oct-23   14:52 )
  Alembic Pharmaceuticals to convene board meeting
 ( Corporate News - 18-Jan-23   10:51 )
  Alembic Pharma gets USFDA nod for Nifedipine tablets
 ( Hot Pursuit - 21-Nov-22   11:14 )
  Alembic Pharmaceuticals fixes record date for interim dividend
 ( Market Beat - Reports 27-Jul-22   14:22 )
  Alembic Pharma Q3 PAT slips 29% YoY; R&D spend at Rs 157 crore
 ( Hot Pursuit - 02-Feb-23   10:41 )
  Alembic Pharmaceuticals AGM scheduled
 ( Corporate News - 06-Jun-23   18:21 )
  Board of Alembic Pharmaceuticals recommends Final Dividend
 ( Corporate News - 05-May-23   17:26 )
  Volumes spurt at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 20-Jul-23   14:30 )
  Alembic Pharmaceuticals receives NCLT approval for scheme of arrangement
 ( Corporate News - 01-Sep-22   12:36 )
  Alembic Pharmaceuticals' injectable facility undergoes USFDA inspection
 ( Corporate News - 01-Sep-22   11:50 )
Other Stories
  Poddar Pigments standalone net profit rises 17.45% in the March 2024 quarter
  20-May-24   07:50
  Choksi Imaging standalone net profit rises 675.00% in the March 2024 quarter
  20-May-24   07:50
  Rainbow Children's Medicare consolidated net profit declines 4.91% in the March 2024 quarter
  20-May-24   07:50
  Sundaram Home Finance standalone net profit declines 12.99% in the March 2024 quarter
  20-May-24   07:17
  Madhucon Projects reports consolidated net profit of Rs 4.76 crore in the March 2024 quarter
  20-May-24   07:17
  Parag Milk Foods consolidated net profit declines 56.11% in the March 2024 quarter
  20-May-24   07:17
  Jindal Capital reports standalone net loss of Rs 0.06 crore in the March 2024 quarter
  18-May-24   22:51
  Krsnaa Diagnostics consolidated net profit declines 1.00% in the March 2024 quarter
  18-May-24   22:51
  Godha Cabcon and Insulation reports standalone net profit of Rs 1.22 crore in the March 2024 quarter
  18-May-24   22:48
  Tide Water Oil Co (I) consolidated net profit rises 24.73% in the March 2024 quarter
  18-May-24   22:38
Back Top